BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 34200679)

  • 21. SOX11 augments BCR signaling to drive MCL-like tumor development.
    Kuo PY; Jatiani SS; Rahman AH; Edwards D; Jiang Z; Ahr K; Perumal D; Leshchenko VV; Brody J; Shaknovich R; Ye BH; Parekh S
    Blood; 2018 May; 131(20):2247-2255. PubMed ID: 29615403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CCL19 and CXCL12 trigger in vitro chemotaxis of human mantle cell lymphoma B cells.
    Corcione A; Arduino N; Ferretti E; Raffaghello L; Roncella S; Rossi D; Fedeli F; Ottonello L; Trentin L; Dallegri F; Semenzato G; Pistoia V
    Clin Cancer Res; 2004 Feb; 10(3):964-71. PubMed ID: 14871974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current approaches to epigenetic therapy for the treatment of mantle cell lymphoma.
    Ghai V; Sharma K; Abbi KK; Shimko S; Epner EM
    Adv Exp Med Biol; 2013; 779():257-66. PubMed ID: 23288643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitors of BCR signalling interrupt the survival signal mediated by the micro-environment in mantle cell lymphoma.
    Bernard S; Danglade D; Gardano L; Laguillier C; Lazarian G; Roger C; Thieblemont C; Marzec J; Gribben J; Cymbalista F; Varin-Blank N; Ledoux D; Baran-Marszak F
    Int J Cancer; 2015 Jun; 136(12):2761-74. PubMed ID: 25388373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of the SRC-family tyrosine kinase HCK as a therapeutic target in mantle cell lymphoma.
    Lantermans HC; Minderman M; Kuil A; Kersten MJ; Pals ST; Spaargaren M
    Leukemia; 2021 Mar; 35(3):881-886. PubMed ID: 32591642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell adhesion receptors in lymphoma dissemination.
    Drillenburg P; Pals ST
    Blood; 2000 Mar; 95(6):1900-10. PubMed ID: 10706853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The immune microenvironment in malignant lymphoma].
    Nishikori M
    Rinsho Ketsueki; 2019; 60(9):1229-1235. PubMed ID: 31597848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interrogating B cell signaling pathways: A quest for novel therapies for mantle cell lymphoma.
    Ahmed M; Lorence E; Wang J; Jung D; Zhang L; Nomie K; Wang M
    Sci Signal; 2019 Feb; 12(567):. PubMed ID: 30723172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rationale for targeting tumor cells in their microenvironment for mantle cell lymphoma treatment.
    Papin A; Le Gouill S; Chiron D
    Leuk Lymphoma; 2018 May; 59(5):1064-1072. PubMed ID: 28758825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of Bruton's tyrosine kinase in B cells and malignancies.
    Pal Singh S; Dammeijer F; Hendriks RW
    Mol Cancer; 2018 Feb; 17(1):57. PubMed ID: 29455639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and role of MIG/CXCR3 axis in mantle cell lymphoma.
    Zhu MX; Wan WL; Hong Y; Wang YF; Dong F; Jing HM
    Exp Cell Res; 2020 Dec; 397(2):112365. PubMed ID: 33197439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What Is Responsible for Heterogeneity in Mantle Cell Lymphoma Biology and Outcomes?
    Witzig TE
    Hematol Oncol Clin North Am; 2020 Oct; 34(5):825-835. PubMed ID: 32861280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The STAT3 inhibitor WP1066 synergizes with vorinostat to induce apoptosis of mantle cell lymphoma cells.
    Lu K; Chen N; Zhou XX; Ge XL; Feng LL; Li PP; Li XY; Geng LY; Wang X
    Biochem Biophys Res Commun; 2015 Aug; 464(1):292-8. PubMed ID: 26116769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B cell lymphomas express CX3CR1 a non-B cell lineage adhesion molecule.
    Andréasson U; Ek S; Merz H; Rosenquist R; Andersen N; Jerkeman M; Dictor M; Borrebaeck CA
    Cancer Lett; 2008 Feb; 259(2):138-45. PubMed ID: 18060687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic targeting in mantle cell lymphoma.
    Dunleavy K
    Br J Haematol; 2019 Sep; 186(6):805-806. PubMed ID: 31489625
    [No Abstract]   [Full Text] [Related]  

  • 36. Lymphocyte homing and homeostasis.
    Butcher EC; Picker LJ
    Science; 1996 Apr; 272(5258):60-6. PubMed ID: 8600538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of Lyn is a promising treatment for mantle cell lymphoma with bortezomib resistance.
    Kim A; Seong KM; Kang HJ; Park S; Lee SS
    Oncotarget; 2015 Nov; 6(35):38225-38. PubMed ID: 26517678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bifurcated BACH2 control coordinates mantle cell lymphoma survival and dispersal during hypoxia.
    Zhang H; Chen Z; Miranda RN; Medeiros LJ; McCarty N
    Blood; 2017 Aug; 130(6):763-776. PubMed ID: 28592433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mantle cell lymphomas express a distinct genetic signature affecting lymphocyte trafficking and growth regulation as compared with subpopulations of normal human B cells.
    Ek S; Högerkorp CM; Dictor M; Ehinger M; Borrebaeck CA
    Cancer Res; 2002 Aug; 62(15):4398-405. PubMed ID: 12154046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of cannabinoid receptors and the endocannabinoid system in mantle cell lymphoma and other non-Hodgkin lymphomas.
    Wasik AM; Christensson B; Sander B
    Semin Cancer Biol; 2011 Nov; 21(5):313-21. PubMed ID: 22024769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.